Archit Organosys Faces Evaluation Adjustment Amid Mixed Financial and Technical Indicators
Archit Organosys, a microcap chemicals company, has experienced a recent adjustment in its evaluation score, influenced by technical indicators and financial metrics. Despite a positive Q3 FY24-25 performance, challenges in long-term growth and underperformance against market indices have shaped the company's current market dynamics and financial health.
Archit Organosys, a microcap player in the chemicals industry, has recently undergone an adjustment in its evaluation score. This revision reflects a combination of technical indicators and underlying financial metrics that have shaped the company's market position. The stock's technical trends have shifted to a mildly bearish stance, as indicated by various technical factors such as MACD and KST, which suggest a mixed outlook. Despite a positive financial performance reported for Q3 FY24-25, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of 6.61% over the past five years.
Additionally, the return on capital employed (ROCE) stands at 8.65%, which points to weak long-term fundamental strength. The stock has also underperformed relative to broader market indices, generating a return of -10.57% over the past year.
Overall, the adjustment in Archit Organosys' evaluation reflects a nuanced view of its current market dynamics and financial health.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
